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Department of General Practice, Erasmus MC, University Medical Center Rotterdam, The Netherlands
ABSTRACT
Objective: To examine whether significant differences exist between the self-reported prevalence
of atopic disorders in the open population compared with physician diagnosed prevalence of
atopic disorders in general practice. Methods: Medline (OvidSP), PubMed Publisher, EMBASE,
Google Scholar and the Cochrane Controlled Clinical Trials Register databases were systematically
reviewed for articles providing data on the prevalence of asthma, allergic rhinitis and eczema in
a GP setting. Studies were only included when they had a cross-sectional or cohort design and
included more than 100 children (aged 0-18 years) in a general practice setting. All ISAAC studies
(i.e. the open population) that geographically matched a study selected from the first search,
were also included. A quality assessment was conducted. The primary outcome measures were
prevalence of eczema, asthma and allergic rhinitis in children aged 0-18 years. Results: The over-
all quality of the included studies was good. The annual and lifetime prevalences of the atopic
disorders varied greatly in both general practice and the open population. On average, the preva-
lence of atopic disorders was higher in the open population. Conclusion: There are significant
differences between the self-reported prevalence of atopic disorders in the open population com-
pared with physician diagnosed prevalence of atopic disorders in general practice. Data obtained
in the open population cannot simply be extrapolated to the general practice setting. This should
be taken into account when considering a research topic or requirements for policy development.
GPs should be aware of the possible misclassification of allergic disorders in their practice.
KEY POINTS
 Epidemiological data on atopic disorders in children can be obtained from various sources, each
having its own advantages and limitations.
 On average, the prevalence of atopic disorders is higher in the open population.
 GPs should take into account the possible misclassification of atopic disorders in their practice
population.
 Policymakers should be aware that data obtained in the open population cannot simply be
extrapolated to the general practice setting.
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Introduction
The atopic syndrome is a predisposition toward an
exaggerated IgE-mediated immune response in reaction
to an allergen. A patient with atopy typically presents
with one or more of the following disorders: eczema
(atopic dermatitis), asthma or allergic rhinitis. In this art-
icle atopic disorders refer to allergic manifestations for
which atopy is a prerequisite. Epidemiological data on
atopic disorders in children can be obtained from vari-
ous sources, each having its own advantages and limi-
tations. This review examines data obtained from
general practice and survey data obtained in the open
population. Depending on the research topic or the
requirements for policy development, reliable data from
either the open population or general practice (or both)
might be needed.
The International Study of Asthma and Allergies in
Childhood (ISAAC) has yielded many publications
related to the open population.[1] Albeit such survey
data provide useful information on the prevalence of
self-reported symptoms of allergic disorders and the
derived diagnosis,[2] they also imply a risk of overesti-
mation of the prevalence of atopic disorders. For
example, a runny nose can be caused by allergic
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rhinitis or by a viral upper airway infection; distinguish-
ing between these two causes may be difficult for a
patient when completing a questionnaire. Although
the prevalence based on a clinician-diagnosed disease
might solve this problem, it will imply a risk of under-
estimation of the burden of disease. For example,
patients might have a ‘‘threshold’’ with regard to visit-
ing a physician or might consider their complaints not
serious enough to visit one. Because, epidemiological
data on atopic conditions in children in a general prac-
tice are scarce, we performed a systematic review.
We expected to find a significant difference
between the self-reported prevalence in the open
population (ISAAC studies) and the clinician-diagnosed
prevalence of a disease in general practice. More
insight into these differences may help policy-makers
to optimize their policies and help general practitioners
(GPs) become more aware about the possible under-
diagnosis of allergic conditions in children.
Methods
Search strategy
Two separate search strategies were used to collect
data on the two sources (i.e., general practice and open
population). First, a comprehensive search for relevant
studies in general practice was performed in Medline
(OvidSP), PubMed Publisher, EMBASE, Google Scholar
and the Cochrane Controlled Clinical Trials Register
databases. The search strategy (Appendix) combined
the following items: ‘‘Child’’ AND ‘‘Epidemiology’’ AND
‘‘Asthma’’ AND ‘‘Allergic rhinitis’’ AND ‘‘Eczema’’. All
articles in these five databases were considered and
reviewed; no language restriction was imposed and the
search was completed in January 2015. All references of
the included studies were examined in order to be as
comprehensive as possible.
A second search, performed in the ISAAC database,
was also conducted in January 2015. ISAAC provides its
users with a database that holds citations on all publica-
tions which are part of the ISAAC collaboration,[1] repre-
senting the open population. However, because of
known regional differences,[3] we looked for studies
that geographically matched (i.e., the same country) the
studies finally selected in the first search strategy.
Study selection
Based on title and abstract, two reviewers (DP and
EvA) independently selected articles retrieved in the
first search strategy. All studies that provided data on
the prevalence of asthma, allergic rhinitis, and eczema
were considered, so long as they had a cross-sectional
or cohort design and included more than 100 children
(0–18 years) in a general practice setting. If the
abstract was not conclusive regarding these items, the
article was included for full-text assessment. Any dis-
agreement was resolved in a consensus meeting.
Finally, the full-text of the selected abstracts was inde-
pendently reviewed by two reviewers (DP and JW).
Studies were not included if they did not meet the
above-mentioned inclusion criteria or if selection bias
was present (e.g., data were retrieved from a specific
cohort within a general practice setting).
The second search strategy focused on the ISAAC
database.[1] Two reviewers (DP and JW) independently
checked this database for relevant articles. All studies
were included that geographically matched (i.e., the
same country) a study selected from the first search.
Quality assessment
The quality of the included studies was independently
assessed by two reviewers (DP and AB). Any disagree-
ment was resolved in a consensus meeting.
Assessment of the quality of the finally included
studies conducted in general practice, was done by
scoring the following items: population size, descrip-
tion of participants (age and percentage males), study
year, data sources (paper or digital patient files, struc-
tured interviews, etc.), selection bias (e.g., not using all
patient files but a selection thereof) and whether or
not the methods used are reproducible. With regard to
reproducibility, the emphasis was on the definitions
used for asthma, allergic rhinitis and eczema.
ISAAC used a standardized method. Ellwood et al.
showed that the ISAAC methodology could be repli-
cated to a high standard by the majority of participat-
ing centers.[4] This indicates that the ISAAC protocol is
robust and working in accordance with this protocol
implies high quality. Any important violations of this
protocol were obtained for the quality assessment of
the finally included studies.
Data extraction
All data extraction was independently performed by
two reviewers (DP and AB). Data were collected on the
number of children studied, study period, study design,
and country. The outcome measures are the prevalen-
ces of eczema, asthma, and allergic rhinitis in children
aged 0–18 years.
Results
Selection and description of the literature
The search strategy regarding general practice yielded
4274 unique articles. Most of these (n¼ 4242) did not
144 D. H. J. POLS ET AL.
D
ow
nl
oa
de
d 
by
 [E
ras
mu
s U
niv
ers
ity
] a
t 0
6:3
5 0
1 D
ec
em
be
r 2
01
7 
meet the inclusion criteria, mainly because only 2.2%
of these studies (n¼ 95) were conducted in a general
practice setting. Of the 34 articles retrieved for full-text
evaluation, 28 were excluded because they did not
meet the inclusion criteria.
Finally, six studies were included in the present
review for further analysis with regard to general prac-
tice; one study was performed in the Netherlands [5]
and five in the UK.[6–10] These six studies were pub-
lished between 1974 and 2009. In Table 1 the results
of the quality assessment are presented. There was no
evidence of selection bias. Four of the six studies had
an adequate description of the methodology, whereas
two studies failed to describe the exact definitions
used for the disorders examined. Two studies pre-
sented data on annual prevalence and four UK studies
presented data on lifetime prevalence.
The ISAAC database contained 604 articles. Of these,
seven eligible studies [11–17] were selected that could
be geographically matched to the selected general
practice studies. Of these, six were performed in the
UK [11–16] and one in the Netherlands.[17] All six UK
studies were conducted between 1995 and
2002.[11–16] The study on Dutch adolescents was con-
ducted in 2003.[17]. Table 2 presents the results of the
quality assessment of these studies.
Eczema
The annual and lifetime prevalences of the atopic dis-
orders varied widely between the studies and the pop-
ulations involved. The annual prevalence (Table 3) of
eczema ranged from 1.8%- to 9.5% in general practice
and from 11.4% to 24.2% in the open population,
Table 1. Study characteristics and quality items general practice studies.
First author/year Country No. analyzed Age (years) Males (%) Study year Data sources Biasa Reproducible
Blair [6] UK 1907 0–10 53.2 1970–1973 Paper filesþ interview No No
Mortimer et al. [9] UK 1077 3–11 50.5 <1993 Interviewsþ survey No No
Punekar and Sheikh [8] UK 24,112 0–18 51.1 1990–2008 Digital files No Yes
Simpson et al. [7] UK 252,538b 0–14 53.6 1999 Digital files No Yes
Simpson et al. [10] UK 492,411/486,804 0–14 49.6/49.8 2001/2005 Digital files No Yes
Wijga and Beckers [5,35] NL 79,272 0–17 51.3 2001 Digital filesþ interviews No Yes
aNot using the entire patient files, but some selection thereof.
bTotal study population, including adults.
Table 2. Study characteristics and quality items of the open population (ISAAC) studies.
First author/year Country No. analyzed Age (years) Males (%) Response rate (%) Study year English questionnaires Violations protocola
Austin [12] UK 27,507 12–14 49.2 85.9 1995 Yes 3, 6
Jeffs [16] UK 3772 12–14 – 90.7 1995–1996 Yes 3
Priftanji [13] UK 1050 13–14 – 79 1998–2001 Yes 5, 6, 7
Anderson [11] UK 15,083/15,755 12–14 – 87 1995/2002 Yes 3, 6
Austin [15] UK 4298 12–15 49.1 89 2002 Yes 3, 6
Shamssain [14] UK 6000 6–7/13–14 48.5/50.3 80–90 1995–1996 Yes 6
UK 4038 6–7/13–14 49.8/45.6 90–92 2001–2002 Yes 7
Ven [17] NL 9713 12–14 48.8 91.2 2003 No None
a1) Recruitment at schools; 2) All schools, or randomly selected; 3) Age groups 6–7/13–14 years; 4) Use of validated questionnaires; 5) questionnaires com-
pleted by parents (<12 year olds) or by adolescents themselves (12 year olds); 6) Participation >90%; and 7) N 3000.
Table 3. Studies presenting annual prevalence.
Study Source Country No. included Time period Age group (years) Eczema (%) Asthma (%) Allergic rhinitis (%)
Wijga and Beckers [5,35] General Practice NL 79,272 2001 0–9 5.5 5.3 0.4
10–17 1.8 3.0 0.4
Ven et al. [17] Open Population NL 9713 2003 12–14 13.5 12.3 28.3
Simpson et al. [7] General Practice UK 252,538a 1999 0–4 9.5b 4.3b 0.7b
5–9 4.5b 6.5b 2.3b
10–14 3.4b 6.2b 4.1b
Austin et al. [12] Open Population UK 27,507 1995 12–14 16.4 33.3 18.2
Jeffs et al. [16] Open Population UK 3772 1995–1996 12–14 22.7 34.2 37.8
Anderson et al. [11] Open Population UK 15,083 1995 12–14 16.2 33.9 18.4
Anderson et al. [11] Open Population UK 15,755 2002 12–14 11.4 27.5 15.1
Austin et al. [15] Open Population UK 4298 2002 12–15 12.0 27.8 15.3
Shamssain [14] Open Population UK 3000 1995–1996 6–7 15.8 18.1 20.6
3000 13–14 17.0 19.9 29.6
Shamssain [14] Open Population UK 1843 2001–2002 6–7 24.2 25.4 15.8
2195 13–14 19.0 22.2 32.2
aTotal study population.
bPrevalences calculated based on the assumption of male/female ratio ¼ 1.04:1.00.
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whereas the lifetime prevalences (Table 4) ranged from
7.2% to 36.5% in general practice and from 16.5% to
27.1% in the open population.
Asthma
In general practice, the annual prevalence (Table 3) of
asthma ranged from 3.0% to 6.5%, whereas in the
open population it was as high as 18.1%–34.2%. The
lifetime prevalence (Table 4) of asthma in general prac-
tice was 4.2%–22.9% compared with 19.1%–35.6% in
the open population.
Allergic rhinitis
In general practice the annual prevalence (Table 3) of
allergic rhinitis ranged from 0.4% to 4.1% compared
with 15.1%–37.8% in the open population; the lifetime
prevalence (Table 4) ranged from 1.0% to 11.4% in
general practice and from 18.3% to 47.7% in the open
population.
Differences between the Netherlands and the UK
In both the Netherlands and the UK, similar differences
exist between the prevalences of the atopic diseases in
the open population and the general practice popula-
tion (Figure 1). In general practice the annual preva-
lence of eczema and asthma are very similar. There is
a large difference in the prevalence of diagnosed aller-
gic rhinitis: in the UK this diagnosis is registered more
frequently (0.4% versus 2.4%). On the other hand, in
the open population there is a higher prevalence of
allergic rhinitis in the Netherlands (28.3%) compared to
that of the UK (19.3%). Finally, a substantial difference
exists between the two countries in the annual preva-
lence of asthma in the open population (12.3% versus
30.3%). Unfortunately, the data were not sufficient to
allow comparisons at the regional level.
Discussion
Summary
On average, the prevalence of all three atopic disor-
ders was substantially higher in the open population
compared to general practice. For example, the annual
prevalence of asthma ranged from 3.0% to 6.5% in
general practice compared to 18.1%–34.2% in the
open population. At least a twofold difference. In both
the Netherlands and the UK similar differences were
found between the open population and the general
practice population. Allergic rhinitis was an exception
and was diagnosed more frequently in the UK by GPs
(0.4% versus 2.4%) whereas a higher prevalence was
found in the Netherlands in the open population
(28.3% versus 19.3%). Our results implicate that data
obtained in the open population cannot simply be
Table 4. UK studies, lifetime prevalence.
Study Source No. included Time period Age group (years) Eczema (%) Asthma (%) Allergic rhinitis (%)
Blair [6] General practice 1907 1970–1973 0–10 7.2 6.3 4.8
Mortimer et al. [9] General practice 1077 <1993 3–11 20.2 19.6 7.6
Simpson et al. [10] General practice 126,348 2001 0–4 13.0a 6.3 1.0a
366,063 5–14 13.0a 15.7 4.5a
Simpson et al. [10] General practice 125,020 2005 0–4 18.0a 4.2 1.4a
5–14 19.0a 15.7 6.7a361,784
Punekar and Sheikh [8] General practice 24,112 2008 0–18 36.5 22.9 11.4
Austin et al. [12] Open population 27,507 1995 12–14 22.5 20.9 34.9
Jeffs et al. [16] Open population 3772 1995–1996 12–14 25.6 19.1 47.7
Priftanji et al. [13] Open population 1050 1998–2001 13–14 27.1 20.2 19.5
Anderson et al. [11] Open population 15,083 1995 12–14 21.1 20.6 34.8
Anderson et al. [11] Open population 15,755 2002 12–14 24.3 25.9 37.4
Austin et al. [15] Open population 4298 2002 12–15 25.0 24.5 34.1
Shamssain [14] Open population 3000 1995–1996 6–7 18.3 29.3 22.6
3000 13–14 17.2 31.6 33.7
Shamssain [14] Open population 1843 2001–2002 6–7 21.8 35.6 18.3
2195 13–14 16.5 30.5 25.6
aEstimation based on graph.
0
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10
15
20
25
30
35
Eczema GP Eczema OP Asthma GP Asthma OP AR GP AR OP
NL
UK
Figure 1. Annual prevalence in % (weighted mean): General
Practice (GP) versus Open Population (OP) in UK (United
Kingdom) and NL (The Netherlands). (AR¼ allergic rhinitis).
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extrapolated to the general practice setting. This
should be taken into account when considering a
research topic or requirements for policy development.
GPs should be aware of possible underdiagnosis of
allergic disorders in their practice. However, overesti-
mation can also occur due to misclassification of the
disorder by a GP.[18,19]
Strengths and limitations
No articles were excluded in this review based on lan-
guage restrictions. All articles were independently
examined by two reviewers, all references of the
included studies were also checked and all data extrac-
tion was done by two independent researchers.
The search strategy for the open population focused
exclusively on the ISAAC database, with three related
limitations. First, although the ISAAC study has yielded
many international publications, restricting our review
to official ISAAC studies carries the risk of missing
other relevant studies using different, but also vali-
dated, methodologies. A recently published meta-
analysis based on both official and non-official ISAAC
questionnaires showed annual prevalences for eczema,
asthma, and allergic rhinitis of 7.9%, 12.0%, and 12.7%,
respectively.[2] These prevalences are lower than the
average annual prevalences that were observed in this
review. It suggests the possibility of an higher estima-
tion of the prevalence of atopic disorders when only
ISAAC studies are included. However, using one meth-
odology allowed us to make safer comparisons, espe-
cially because ISAAC’s methodology is known to be
solid. The second limitation is the ISAAC database
itself, which we discovered is not 100% comprehen-
sive. The third limitation is the cross-sectional design
of ISAAC and of the studies in general practice. Okkes
et al. studied the differences between general practice
registration projects and a health survey.[20] They con-
sidered an observation period of one year to be a
source of problems; using data collected over a longer
period of time showed more accuracy.[20]
Since the definition of atopic disorders has changed
over time, one could argue that the conclusions
reached in this article do not take these changes into
consideration. However, this argument does not hold
for ISAAC, since ISAAC uses the same definition to
define atopic disorders since its beginning in 1991. For
studies conducted in general practice, this might be
different, but cannot explain the remarkable difference
between the two settings.
Finally, we included only two countries. We focused
on general practice and not every country has a GP in
its healthcare system. The use of other sources of
primary care data is subject to more selection bias and
was therefore avoided.
Comparison with existing literature
Existing literature provides various explanations for the
wide variability found between the two settings. First,
the worldwide prevalence of the three disorders has
changed over time.[3] The studies in this review were
conducted between 1970 and 2008 and the reported
prevalence might in part, reflect this worldwide time
trend. Another explanation for changing prevalences
over time is a change in definitions of atopic disorders
over time. Van Wonderen et al. found 60 different
operational definitions used in the literature on
asthma.[21] Applied in a single cohort, there was a
substantial variation in estimated prevalences depend-
ing on the operational definition used. To deal with
the remarkable amount of different definitions in
atopic disorders worldwide, expert teams were given
the task of finding consensus. For example, in 2006 a
consensus regarding the diagnosis and treatment of
atopic dermatitis was developed for this reason.[22]
Furthermore, for the lifetime prevalence, the age
groups differed between the studies, resulting in differ-
ent prevalences. Finally, not all GPs may be fully aware
of what their patients actually experience regarding
allergic symptoms [23] which might lead to misclassifi-
cation of allergic and therefore atopic diagnoses.
Especially allergic rhinitis might be underestimated,
since anti-allergic medication (antihistamines) is freely
available over-the-counter thereby limiting the neces-
sity for patients to visit their GP for related symptoms.
Data from both sources have both advantages and
disadvantages as proven by existing literature. Data
obtained from general practice databases can be con-
sidered specific, but not very sensitive. This lack of sen-
sitivity might be the result of underdiagnosis or
misclassification.[19] This risk is particularly true for
asthma. Spirometry under the age of six years is not
considered reliable, resulting in a probability or clinical
diagnosis. In other cases, spirometry is often under-
used or the technique is poor.[19] Misclassification can
also be the result of the differences of ‘‘conceptual
vocabulary’’ between parents and clinicians.[24] On the
other hand, a prevalence based on self-administered
questionnaires will result in more sensitive data, but
will be less specific. Questionnaires are often used in
population studies mainly for epidemiological pur-
poses. Although ISAAC put considerable effort into the
validation of their questionnaires,[25–28] external influ-
ences cannot be totally ruled out. The accuracy of data
obtained from a questionnaire always depends on
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 147
D
ow
nl
oa
de
d 
by
 [E
ras
mu
s U
niv
ers
ity
] a
t 0
6:3
5 0
1 D
ec
em
be
r 2
01
7 
various influences, including the accuracy, and know-
ledge of the responders and the definitions used.
ISAAC uses dichotomous (Yes/No) definitions. There is
evidence that suggests that using continuous (graded)
definitions would result in better statistical power and
will provide relevant additional information.[29] Also
the terminology used in a questionnaire influences the
results. Wheeze for example is the cornerstone of
asthma diagnosis. However, conceptual understandings
of ‘‘wheeze’’ differs between physicians, researchers
and parents of children with reported wheeze. This dif-
ference will influence reported prevalences in the open
population (using questionnaires) and clinical practice
(using a physician interpretation of wheeze).[24]
Dotterud et al. [30] considered questionnaires on
atopic conditions a useful epidemiological tool for
obtaining rough estimates of the prevalence of atopic
disorders. They conclude that eczema was generally
underestimated and allergic rhinitis overestimated
when using questionnaires in the open population;[30]
the present study seems to confirm their findings.
Furthermore, different prediction scores have been
developed based on data from the open population
and from general practice. For example, the PIAMA
Risk Score, based on the open population, helps to
predict which child with suggestive symptoms for
asthma could develop asthma at school age,[31]
whereas the CAPS prediction score was developed in a
primary care setting.[32] Both models differ substan-
tially with regard to the factors they take into account;
this difference might be explained by the different
reported prevalences. When using prediction scores, it
is important to be aware of the setting in which they
were developed and validated.
Implications for research and practice
The prevalences of the three atopic disorders were on
average higher in the open population compared with
general practice. However, the degree of difference
varied depending on the specific disorder.
Policymakers should be aware that survey based data,
obtained in the open population, cannot simply be
extrapolated to the general practice setting.
GPs should consider critically reevaluating the
already diagnosed atopic disorders in a patient’s med-
ical record to reduce the risk of misclassification. The
present data may also serve to prompt GPs to be
more aware of possibly underdiagnosed atopic condi-
tions in children. For example, a relatively large per-
centage of children in the open population reported
symptoms of allergic rhinitis; confirming the results of
Dotterud et al. based on survey data.[30] The low
prevalences found in general practice do not reflect
this. Knowing that poorly regulated allergic rhinitis can
have an influence on asthma regulation[33], our data
emphasizes the importance of actively asking about
allergic rhinitis symptoms in children with asthma. GPs
should consider different atopic disorders when a child
is already diagnosed with one, since the atopic disor-
ders are closely related.[2]
Future research could benefit from longitudinal
research with standardizing diagnostic definitions and
by standardized reporting (e.g., reporting lifetime preva-
lence’s at standardized ages). Diagnosing an atopic dis-
order in general practice can be difficult, even if a clear
definition is used. GPs often work with probability diag-
nosis and have to label their consultations with a stand-
ardized code like the International Classification of
Primary Care (ICPC). ICPC is accepted by the WHO for
labeling primary care encounters.[34] Using ICPC codes
in epidemiological studies implies a risk of dealing with
misclassification, since some of the diagnosis should be
regarded as ‘‘probability diagnosis’’ and not as ‘‘true
diagnosis’’. When analyzing electronic medical records
from a GP with the use of ICPC codes; duration of fol-
low-up, number of consultations, and number of rele-
vant prescriptions for that specific ICPC code should be
taken into account. In this way, ICPC codes could be cor-
rected, reducing the risk of misclassification. Regarding
allergic rhinitis there is also another problem. GP regis-
trations could show an underestimation of the number
of children with allergic rhinitis due to the availability of
‘‘over the counter’’ (OTC) drugs for this disorder. ‘‘This
may explain the higher observed prevalences for aller-
gic rhinitis in the open population’’.
In conclusion, significant differences exist between
the self-reported prevalence of atopic disorders in the
open population compared with physician diagnosed
prevalence of atopic disorders in general practice. Data
obtained in the open population cannot simply be
extrapolated to general practice setting. GPs should be
aware of possible misclassification of allergic disorders
in their practice. Some suggestions how to limit this
risk of misclassification in epidemiological research are
given.
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Appendix
Search strategy
Embase (asthma/exp OR wheezing/de OR (asthma* OR
wheez* OR hyperresponsiv* OR hypersensit* OR (hyper NEXT/
1 (responsiv* OR sensitiv*))):ab,ti) AND (eczema/de OR ’atopic
dermatitis’/de OR (eczem* OR (atopic NEAR/3 dermati-
t*)):ab,ti) AND (rhinitis/exp OR conjunctivitis/exp OR (rhinitis*
OR rhinoconjunctivit* OR conjunctivit* OR (Pollen NEAR/3
Allerg*) OR Pollinos* OR ((hay) NEXT/1 (fever*)) OR hayfever):-
ab,ti) AND (Epidemiology/exp OR ’epidemiological data’/exp
OR epidemiology:lnk OR (prevalenc* OR inciden* OR trend*
OR associat* OR comorbid* OR relat* OR correlat* OR (case
NEAR/3 (control* OR comparison OR referent)) OR epidemio-
log* OR cohort* OR risk* OR caus* OR (odds NEXT/1 ratio*)
OR etiol* OR aetiol* OR (natural NEXT/1 histor*) OR predict*
OR prognos* OR outcome* OR course*):ab,ti) AND (child/exp
OR newborn/exp OR adolescent/exp OR adolescence/exp OR
’child behavior’/de OR ’child parent relation’/de OR (adoles-
cen* OR infan* OR newborn* OR (new NEXT/1 born*) OR
baby OR babies OR neonat* OR child* OR kid OR kids OR
toddler* OR teen* OR boy* OR girl* OR minors OR underag*
OR (under NEXT/1 ag*) OR juvenil* OR youth* OR kindergar*
OR puber* OR pubescen* OR prepubescen* OR prepubert*
OR pediatric* OR paediatric* OR school* OR preschool* OR
highschool*):ab,ti)
Medline via OvidSP (exp asthma/OR (asthma* OR wheez*
OR hyperresponsiv* OR hypersensit* OR (hyper ADJ (respon-
siv* OR sensitiv*))).ab,ti.) AND (exp Dermatitis, Atopic/OR exp
Eczema/OR Eczem*.ab,ti. OR (atopic ADJ3 dermatit*).ab,ti.)
AND (exp Rhinitis/OR exp Conjunctivitis/OR (rhinit* OR rhino-
conjunctivit* OR conjunctivit* OR (Pollen ADJ3 Allerg*) OR
Pollinos* OR hayfever* OR hay fever*).ab,ti.) AND (exp
Epidemiologic Studies/OR exp Epidemiologic Factors/OR epi-
demiology.xs. OR (prevalenc* OR inciden* OR trend* OR
associat* OR comorbid* OR relat* OR correlat* OR (case ADJ3
(control* OR comparison OR referent)) OR epidemiolog* OR
cohort* OR risk* OR caus* OR odds ratio* OR etiol* OR aetiol*
OR natural histor* OR predict* OR prognos* OR outcome* OR
course*).ab,ti.) AND (exp child/OR exp infant/OR (infan* OR
newborn* OR new born* OR baby OR babies OR neonat* OR
perinat* OR postnat* OR child* OR kid? OR toddler* OR teen*
OR boy? OR girl? OR minor? OR underag* OR (under ADJ2
ag?) OR juvenil* OR youth? OR kindergar* OR puber* OR
pubescen* OR prepubescen* OR prepuberty* OR pediatric*
OR peadiatric* OR school* OR preschool* OR highschool* OR
suckling*).ab,ti. OR ((adoles*.ab,ti. OR adolescent/) NOT exp
adult/))
Cochrane ((asthma* OR wheez* OR hyperresponsiv* OR
hypersensit* OR (hyper NEXT/1 (responsiv* OR sensiti-
v*))):ab,ti) AND ((eczem* OR (atopic NEAR/3 dermatit*)):ab,ti)
AND ((rhinitis* OR rhinoconjunctivit* OR conjunctivit* OR
(Pollen NEAR/3 Allerg*) OR Pollinos* OR ((hay) NEXT/1
(fever*)) OR hayfever):ab,ti) AND ((prevalenc* OR inciden* OR
trend* OR associat* OR comorbid* OR relat* OR correlat* OR
(case NEAR/3 (control* OR comparison OR referent)) OR epi-
demiolog* OR cohort* OR risk* OR caus* OR (odds NEXT/1
ratio*) OR etiol* OR aetiol* OR (natural NEXT/1 histor*) OR
predict* OR prognos* OR outcome* OR course*):ab,ti) AND
((adolescen* OR infan* OR newborn* OR (new NEXT/1 born*)
OR baby OR babies OR neonat* OR child* OR kid OR kids OR
toddler* OR teen* OR boy* OR girl* OR minors OR underag*
OR (under NEXT/1 ag*) OR juvenil* OR youth* OR kindergar*
OR puber* OR pubescen* OR prepubescen* OR prepubert*
OR pediatric* OR paediatric* OR school* OR preschool* OR
highschool*):ab,ti)
PubMed publisher (asthma[mh] OR (asthma*[tiab] OR
wheez*[tiab] OR hyperresponsiv*[tiab] OR hypersensit*[tiab]
OR hyper responsiv*[tiab] OR hyper sensitiv*[tiab])) AND
(Dermatitis, Atopic[mh] OR Eczema[mh] OR Eczem*[tiab] OR
(atopic AND dermatit*[tiab])) AND (Rhinitis[mh] OR
Conjunctivitis[mh] OR (rhinit*[tiab] OR rhinoconjunctivit*[tiab]
OR conjunctivit*[tiab] OR (Pollen AND Allerg*[tiab]) OR
Pollinos*[tiab] OR hayfever*[tiab] OR hay fever*[tiab])) AND
(Epidemiologic Studies[mh] OR Epidemiologic Factors[mh] OR
epidemiology[sh] OR (prevalenc*[tiab] OR inciden*[tiab] OR
trend*[tiab] OR associat*[tiab] OR comorbid*[tiab] OR relat*[-
tiab] OR correlat*[tiab] OR (case AND (control*[tiab] OR com-
parison OR referent)) OR epidemiolog*[tiab] OR cohort*[tiab]
OR risk*[tiab] OR caus*[tiab] OR odds ratio*[tiab] OR etiol*[-
tiab] OR aetiol*[tiab] OR natural histor*[tiab] OR predict*[tiab]
OR prognos*[tiab] OR outcome*[tiab] OR course*[tiab])) AND
(child[mh] OR infant[mh] OR (infan*[tiab] OR newborn*[tiab]
OR new born*[tiab] OR baby OR babies OR neonat*[tiab] OR
perinat*[tiab] OR postnat*[tiab] OR child*[tiab] OR kid*
OR toddler*[tiab] OR teen*[tiab] OR boy* OR girl* OR minor*
OR underag*[tiab] OR under ag* OR juvenil*[tiab] OR youth*
OR kindergar*[tiab] OR puber*[tiab] OR pubescen*[tiab] OR
prepubescen*[tiab] OR prepuberty*[tiab] OR pediatric*[tiab]
OR peadiatric*[tiab] OR school*[tiab] OR preschool*[tiab] OR
highschool*[tiab] OR suckling*[tiab]) OR ((adoles*[tiab] OR
adolescent[mh]) NOT adult[mh])) AND publisher[sb]
Google scholar asthma eczema rhinitis prevalence-
incidencejepidemiologyjcohortjriskjetiologyjprognosisjoutcome
adolescentsjinfantsjchildrenjnewborns ‘‘familyjgeneraljprimary
physicianjpracticejdoctorjcare’’.
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